TY - JOUR
T1 - Clinical evaluation of patients with temporomandibular joint implants
AU - Ta, Lauren E.
AU - Phero, James C.
AU - Pillemer, Stanley R.
AU - Hale-Donze, Hollie
AU - McCartney-Francis, Nancy
AU - Kingman, Albert
AU - Max, Mitchell B.
AU - Gordon, Sharon M.
AU - Wahl, Sharon M.
AU - Dionne, Raymond A.
N1 - Funding Information:
This study was supported by the Division of Intramural Research, NIDCR.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2002/12/1
Y1 - 2002/12/1
N2 - Purpose: An undetermined number of patients with temporomandibular joint (TMJ) symptoms have been treated with intra-articular disc implants composed of Teflon ethylene/propylene or Teflon polytetrafluoroethylene and aluminum oxide (Proplast-Teflon; Vitek, Houston, TX). These implants have shown the potential to fragment in situ resulting in nonbiodegradable particles that stimulate a giant cell reaction and lead to degeneration of local structures, pain, and limitation of mandibular opening. We examined the possible relationship between TMJ implants and persistent pain, responses to sensory stimuli, quality of life, and systemic immune dysfunction. Patients and Methods: This case series (32 patients) were referred from university-based orofacial pain centers and private practices from across the United States. Laboratory and clinical assessments evaluated orofacial pain symptoms, neurologic function, clinical signs and symptoms of rheumatologic disease, physical function, systemic measures of immune function, and behavioral measures. Results: We found that TMJ implant patients appeared to have altered sensitivity to sensory stimuli, a higher number of tender points with a diagnosis of fibromyalgia, increased self-report of chemical sensitivity, higher psychologic distress and significantly lower functional ability. Systemic illness or autoimmune disease was not evident in this series of TMJ implant patients. Conclusions: Significant problems were noted on clinical assessment of TMJ implant patients. This is a US government work. There are no restrictions on its use.
AB - Purpose: An undetermined number of patients with temporomandibular joint (TMJ) symptoms have been treated with intra-articular disc implants composed of Teflon ethylene/propylene or Teflon polytetrafluoroethylene and aluminum oxide (Proplast-Teflon; Vitek, Houston, TX). These implants have shown the potential to fragment in situ resulting in nonbiodegradable particles that stimulate a giant cell reaction and lead to degeneration of local structures, pain, and limitation of mandibular opening. We examined the possible relationship between TMJ implants and persistent pain, responses to sensory stimuli, quality of life, and systemic immune dysfunction. Patients and Methods: This case series (32 patients) were referred from university-based orofacial pain centers and private practices from across the United States. Laboratory and clinical assessments evaluated orofacial pain symptoms, neurologic function, clinical signs and symptoms of rheumatologic disease, physical function, systemic measures of immune function, and behavioral measures. Results: We found that TMJ implant patients appeared to have altered sensitivity to sensory stimuli, a higher number of tender points with a diagnosis of fibromyalgia, increased self-report of chemical sensitivity, higher psychologic distress and significantly lower functional ability. Systemic illness or autoimmune disease was not evident in this series of TMJ implant patients. Conclusions: Significant problems were noted on clinical assessment of TMJ implant patients. This is a US government work. There are no restrictions on its use.
UR - http://www.scopus.com/inward/record.url?scp=0036894406&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036894406&partnerID=8YFLogxK
U2 - 10.1053/joms.2002.36089
DO - 10.1053/joms.2002.36089
M3 - Article
C2 - 12464999
AN - SCOPUS:0036894406
SN - 0278-2391
VL - 60
SP - 1389
EP - 1399
JO - Journal of Oral and Maxillofacial Surgery
JF - Journal of Oral and Maxillofacial Surgery
IS - 12
ER -